Pro: “The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.”
Diener, Hans-ChristophVolume:
110
Year:
2013
Language:
english
Journal:
Thrombosis and Haemostasis
DOI:
10.1160/TH13-04-0277
File:
PDF, 214 KB
english, 2013